Cornwall & Isles of Scilly Community Prescribing and Dispensing News: 2017

Month

Topics

No 284
December 2017
Pdf1

  • MHRA Drug Safety Update (November 2017)
  • CAPC Technical Working Group
    Trimbow (beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium bromide)
  • NICE Guidance
    - CG 185 (Nov 17) - Bipolar disorder
    - CG 71 (Nov 17) - Familial hypercholesterolaemia
    - NG81 (Nov 17) - Glaucoma: diagnosis and management
  • NICE Bites - Sinusitis
  • Rivaroxaban

No 283
October 2017
Pdf1

  • MHRA Drug Safety Update (September 2017)
  • NICE Guidance
    - PHE 38 (Sept 17) - Type 2 diabetes: prevention in people at high risk public health
    - NG73 (Sept 17) – Endometriosis: diagnosis and management
    - NG78 (Oct 17) - Cystic fibrosis: diagnosis and management
  • Osteoporosis
    NICE Bites No 100 September/October 2017 includes two related topics:
    - Osteoporosis; assessing the risk of fragility fracture
    - Bisphosphonates for treating osteoporosis
  • Bisphosphonates in osteoporosis

  • Prescribing dilemma
  • Valproate alert
  • Pharmaceutical promotion
  • Adverse drug reaction reporting

No 282
August 2017
Pdf1

  • MHRA Drug Safety Update (June, July and August 2017)
  • NICE Guidance
    - NICE NG 71 (July '17): Parkinson's Disease in adults
    - NICE TA 160 (Aug 17): Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women
    - NICE TA 161 (Aug 17): Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
    - NICE TA 464 (Aug 17): Bisphosphonates (alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid) for treating osteoporosis
  • Shared decision making
  • Report Illicit Drugs Reactions (RIDR)
  • BNF/BNF For Children App
No 281
June 2017
Pdf1
  • MHRA Drug Safety Update (May 2017)
  • NICE Guidance
    - NICE NG 28 (Updated May '17): Type 2 diabetes in adults
  • Quality tip of the month - Anticoagulation in DVT
  • Quinine
  • Strontium
  • Decision aids
  • Rightcare patient decision aids
  • Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines
No 280
May 2017
Pdf1
  • MHRA Drug Safety Update (April 2017)
  • CAPC Technical Working Group
    - Insulin aspart fast acting (Fiasp)
    - Diamorphine nasal spray (Ayendi)
    - ADEK Plus multivitamin tablet
  • NICE Guidance
    - NICE CG 61 (Updated April '17): Irritable bowel syndrome in adults
    - NICE CG 100 (Updated April '17): Alcohol-use disorders
  • Did you see - Fact boxes
  • Did you see - Framing your conversation
  • Shared Care Guidelines
  • Mefenamic acid
No 279
April 2017
Pdf1
  • MHRA Drug Safety Update (March 2017)
  • CAPC Technical Working Group
    - Opicapone (Ongentys)
    - Ulipristal (Esmya)
    - Calcipotriol / betamethasone foam (Enstilar foam)
    - Tiotropium inhaler (Braltus)
  • Eye drop dispensers
  • Valproate
  • Chronic pain - BMA briefing
  • Right Breathe website
  • Clinical reasoning and cognition
No 278
February 2017
Pdf1
  • MHRA Drug Safety Update (January and February 2017)
  • NICE Guidance
    - NICE NG 62 (Jan '17): Cerebral palsy in under 25s
    - NICE NG 63 (Jan '17): Antimicrobial stewardship
    - NICE TA 420 (Dec '16): Ticagrelor for preventing atherothrombotic events after myocardial infarction
  • Expectations of benefits and harms
  • Standards for reviewing inhaler technique
  • Clinical reasoning and cognition
  • Asthma guidelines
  • Opioid prescribing